Web Stats Provided By Google Analytics

Monday, November 25, 2013

FDA Extends Review of Mallinckrodt's NDA for Xartemis XR (oxycodone ...

ST. LOUIS, November 25, 2013-- --Mallinckrodt today announced that the U.S. Food and Drug Administration extended the review of the New Drug Application for investigational compound Xartemis XR Extended-Release Tablets .

http://www.drugs.com/nda/mnk_795_131125.html?
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Popular Healthcare Law Roundup Posts